9-135549322-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_014582.3(OBP2A):c.505G>A(p.Glu169Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000683 in 1,507,616 control chromosomes in the GnomAD database, including 14 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_014582.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OBP2A | NM_014582.3 | c.505G>A | p.Glu169Lys | missense_variant | 6/7 | ENST00000371776.6 | NP_055397.1 | |
OBP2A | NM_001293193.2 | c.436G>A | p.Glu146Lys | missense_variant | 5/6 | NP_001280122.1 | ||
OBP2A | NM_001293189.2 | c.570G>A | p.Ser190Ser | synonymous_variant | 6/7 | NP_001280118.1 | ||
OBP2A | NR_120603.2 | n.609G>A | non_coding_transcript_exon_variant | 6/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OBP2A | ENST00000371776.6 | c.505G>A | p.Glu169Lys | missense_variant | 6/7 | 1 | NM_014582.3 | ENSP00000360841.1 |
Frequencies
GnomAD3 genomes AF: 0.0000546 AC: 8AN: 146638Hom.: 1 Cov.: 25
GnomAD3 exomes AF: 0.0000989 AC: 23AN: 232636Hom.: 5 AF XY: 0.000119 AC XY: 15AN XY: 125846
GnomAD4 exome AF: 0.0000698 AC: 95AN: 1360978Hom.: 13 Cov.: 31 AF XY: 0.0000796 AC XY: 54AN XY: 678812
GnomAD4 genome AF: 0.0000546 AC: 8AN: 146638Hom.: 1 Cov.: 25 AF XY: 0.0000561 AC XY: 4AN XY: 71284
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 21, 2021 | The c.505G>A (p.E169K) alteration is located in exon 6 (coding exon 6) of the OBP2A gene. This alteration results from a G to A substitution at nucleotide position 505, causing the glutamic acid (E) at amino acid position 169 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at